BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
External link for BioSpace
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
We’re investigating biopharma job search plans. Please vote in the poll below, and feel free to share your thoughts in the comments. If you want to keep your comments anonymous, you can contact Angela Gabriel here on LinkedIn or at angela.gabriel@biospace.com.
This content isn’t available here
Access this content and more in the LinkedIn app
The Eli Lilly and Company and Gate Bioscience collaboration focuses on ‘molecular gates,’ a class of molecules that startup Gate says can stop pathogenic proteins from leaving the cell. #moleculargates #molecules #biospace https://xmrrwallet.com/cmx.phubs.li/Q03yVtG10
The European Union’s health regulatory agency did not endorse approving Sarepta Therapeutics' Elevidys for ambulatory patients with Duchenne muscular dystrophy. #genetherapy #pharma #biospace https://xmrrwallet.com/cmx.phubs.li/Q03yVlLn0
As part of its pipeline prioritization initiative, announced on Tuesday, Adicet Bio, Inc is slimming down by 30%. Get the details in our layoff tracker. #layoffs #biopharma #biospace https://xmrrwallet.com/cmx.phubs.li/Q03yVjq10
The strategic reprioritization comes after Rocket Pharmaceuticals hit two major hurdles in the past year, including a clinical hold for an investigational gene therapy and an FDA rejection for its lead asset. #layoffs #fda #biotech #biospace https://xmrrwallet.com/cmx.phubs.ly/Q03yTP_c0
CBER is unanimously against Elevdiys’ return to the market without additional evidence, according to media reports citing an anonymous senior FDA official. Given Elevidys’ full approval, however, experts told BioSpace this path would set up a length legal battle between the regulator and Sarepta Therapeutics. #fda #pharma #biospace https://xmrrwallet.com/cmx.phubs.ly/Q03yTSq00
The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL trial and promised to share more at an upcoming scientific meeting. #pharma #autoimmune #biospace https://xmrrwallet.com/cmx.phubs.li/Q03yLzBd0
The partnership with Matchpoint Therapeutics gets Novartis global rights on all molecules for several unannounced inflammatory diseases identified through the biotech’s discovery platform. #biotech #biospace https://xmrrwallet.com/cmx.phubs.li/Q03yLnHx0
Companies sometimes miss the mark when it comes to telling employees they’re out of a job. From accidental goodbyes to surprise meetings, there are many strange ways biopharma professionals have learned about layoffs. #layoffs #biopharma #biospace https://xmrrwallet.com/cmx.phubs.li/Q03yLndh0
Tessera Therapeutics and Generate:Biomedicines have joined the growing list of biopharmas letting employees go in July. Get the details in our layoff tracker. #layoffs #biopharma #biospace https://xmrrwallet.com/cmx.phubs.li/Q03yLhf30